Skip to content
Screener

Total costs & expenses at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$114M+40.8%
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$2.3B+1,350%
Enterprise value$2.19B+1,537%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001390478-26-000008
Line itemThree Months Ended March 31, 20262025
Operating expenses:
Research and development$5,129$3,205
General and administrative4,1232,858
Total operating expenses9,2526,063
Loss from operations(9,252)(6,063)
Non-operating income:
Interest income845250
Total non-operating income845250

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is SELLAS Life Sciences Group, Inc.'s total costs & expenses?
SELLAS Life Sciences Group, Inc. (SLS) reported total costs & expenses of $9.25M in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s total costs & expenses changed year-over-year?
SELLAS Life Sciences Group, Inc.'s total costs & expenses increased by 52.6% year-over-year, from $6.06M to $9.25M.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total costs & expenses?
Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s total costs & expenses has grown at a -3.7% compound annual growth rate (CAGR), from $32.89M to $28.27M.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating expenditures incurred by the company during a specific reporting period, including research and development activities and general administrative overhead. It serves as a primary indicator of the company's operational burn rate and the financial resources required to sustain clinical development programs. Monitoring this figure is essential for assessing the efficiency of capital deployment in the pursuit of regulatory milestones and therapeutic commercialization.

Ask your AI about SELLAS Life Sciences Group, Inc.'s total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude